235 related articles for article (PubMed ID: 30949913)
1. JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM).
Iida S; Ishida T; Murakami H; Ozaki S; Abe M; Hata H; Shimazaki C
Int J Hematol; 2019 May; 109(5):509-538. PubMed ID: 30949913
[No Abstract] [Full Text] [Related]
2. JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myeloma.
Iida S; Shimazaki C; Abe M; Nakaseko C
Int J Hematol; 2019 Jun; 109(6):633-640. PubMed ID: 30963472
[No Abstract] [Full Text] [Related]
3. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-9. Extranodal NK/T-cell lymphoma, nasal type (ENKL).
Yamaguchi M; Suzuki R
Int J Hematol; 2019 Apr; 109(4):371-376. PubMed ID: 30820835
[No Abstract] [Full Text] [Related]
4. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-5-diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS).
Ohmachi K
Int J Hematol; 2019 Aug; 110(2):131-146. PubMed ID: 31177376
[No Abstract] [Full Text] [Related]
5. Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.
Westin GF; Dias AL; Go RS
Curr Hematol Malig Rep; 2016 Aug; 11(4):271-9. PubMed ID: 27177742
[TBL] [Abstract][Full Text] [Related]
6. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-1. Follicular lymphoma (FL).
Izutsu K
Int J Hematol; 2019 Jul; 110(1):11-19. PubMed ID: 31172373
[No Abstract] [Full Text] [Related]
7. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-6. Burkitt lymphoma (BL).
Ishizawa K
Int J Hematol; 2019 Sep; 110(3):265-271. PubMed ID: 31297687
[No Abstract] [Full Text] [Related]
8. The use of flow cytometry in the diagnosis and monitoring of malignant hematological disorders.
Ward MS
Pathology; 1999 Nov; 31(4):382-92. PubMed ID: 10643011
[TBL] [Abstract][Full Text] [Related]
9. Proactive Consultation by a Clinical Pathologist Prevents Diagnostic Delay in Hematological Malignancies.
Chang CC; Su MJ; Ho JL; Sun JT; Tsai HW; Tang HF; Chu FY
Asian Pac J Cancer Prev; 2016; 17(3):1019-22. PubMed ID: 27039720
[TBL] [Abstract][Full Text] [Related]
10. JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML).
Maeda Y
Int J Hematol; 2024 Apr; 119(4):347-373. PubMed ID: 38483689
[No Abstract] [Full Text] [Related]
11. Recent publications in hematological oncology.
Hematol Oncol; 2007 Sep; 25(3):148-55. PubMed ID: 17957827
[No Abstract] [Full Text] [Related]
12. [Hematology 2010].
Dreyling M; Subklewe M; Braess J; Spiekermann K
Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
[No Abstract] [Full Text] [Related]
13. [JSH guideline for multiple myeloma].
Hata H
Rinsho Ketsueki; 2013 Oct; 54(10):1850-5. PubMed ID: 24064836
[No Abstract] [Full Text] [Related]
14. Hematopoietic cancer and angiogenesis.
Ribatti D; Scavelli C; Roccaro AM; Crivellato E; Nico B; Vacca A
Stem Cells Dev; 2004 Oct; 13(5):484-95. PubMed ID: 15588506
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma.
Chavda SJ; Yong K
Br J Hosp Med (Lond); 2017 Feb; 78(2):C21-C27. PubMed ID: 28165783
[No Abstract] [Full Text] [Related]
16. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.
de Weers M; Tai YT; van der Veer MS; Bakker JM; Vink T; Jacobs DC; Oomen LA; Peipp M; Valerius T; Slootstra JW; Mutis T; Bleeker WK; Anderson KC; Lokhorst HM; van de Winkel JG; Parren PW
J Immunol; 2011 Feb; 186(3):1840-8. PubMed ID: 21187443
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous appearance of dual malignancies of hematopoietic system-multiple myeloma and acute myeloid leukemia.
Shukla J; Patne SC; Singh NK;
Indian J Pathol Microbiol; 2008; 51(1):118-20. PubMed ID: 18417881
[TBL] [Abstract][Full Text] [Related]
18. Treating hematological malignancies with cell therapy: where are we now?
Landoni E; Savoldo B
Expert Opin Biol Ther; 2018 Jan; 18(1):65-75. PubMed ID: 28978241
[TBL] [Abstract][Full Text] [Related]
19. Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies.
Ravi P; Kumar SK; Cerhan JR; Maurer MJ; Dingli D; Ansell SM; Rajkumar SV
Blood Cancer J; 2018 Feb; 8(3):26. PubMed ID: 29531285
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow and peripheral blood stem cell transplantation for malignancy.
Johnson PW; Simnett SJ; Sweetenham JW; Morgan GJ; Stewart LA
Health Technol Assess; 1998; 2(8):1-187. PubMed ID: 9728295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
